ANYGEN Co., Ltd. engages in the development and production of therapeutic peptides. It operates through the following business divisions: Medicinal Peptide Materials, Research Peptide Materials, and Product and Technology Fees. The Medicinal Peptide Materials division includes leuprolin, desmopressin, and clinical peptides. The Research Peptide Materials division offers custom peptides for research and development. The Product and Technology Fees division deals with chemical library. The company was founded on May 2, 2000 and is headquartered in Gwangju, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company